Cargando…
Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
In the last decade, different research groups in the academic setting have developed induced pluripotent stem cell-based protocols to generate three-dimensional, multicellular, neural organoids. Their use to model brain biology, early neural development, and human diseases has provided new insights...
Autores principales: | Costamagna, Gianluca, Comi, Giacomo Pietro, Corti, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961877/ https://www.ncbi.nlm.nih.gov/pubmed/33800815 http://dx.doi.org/10.3390/ijms22052659 |
Ejemplares similares
-
iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery
por: Costamagna, Gianluca, et al.
Publicado: (2019) -
Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models
por: Pranty, Abida Islam, et al.
Publicado: (2022) -
Merits and challenges of iPSC-derived organoids for clinical applications
por: Xu, Ziran, et al.
Publicado: (2023) -
Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
por: Abati, Elena, et al.
Publicado: (2021) -
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021)